Biomolecules & Therapeutics

The Korean Society of Applied Pharmacology (한국응용약물학회)
권호 표지
DOI QR코드

DOI QR Code

Inhibitory Effects of Norwogonin, Oroxylin A, and Mosloflavone on Enterovirus 71

  • Received : 2015.12.09
  • Accepted : 2016.03.03
  • Published : 2016.09.01
Download PDF
⟨ Previous Next ⟩

Abstract

Severe complications associated with EV71 infections are a common cause of neonatal death. Lack of effective therapeutic agents for these infections underlines the importance of research for the development of new antiviral compounds. In the present study, the anti-EV71 activity of norwogonin, oroxylin A, and mosloflavone from Scutellaria baicalensis Georgi was evaluated using a cytopathic effect (CPE) reduction method, which demonstrated that all three compounds possessed strong anti-EV71 activity and decreased the formation of visible CPEs. Norwogonin, oroxylin A, and mosloflavone also inhibited virus replication during the initial stage of virus infection, and they inhibited viral VP2 protein expression, thereby inhibiting viral capsid protein synthesis. However, ribavirin has a relatively weaker efficacy compared to the other drugs. Therefore, these findings provide important information that will aid in the utilization of norwogonin, oroxylin A, and mosloflavone for EV71 treatment.

Keywords

References

  1. Badran, S. A., Midgley, S., Andersen, P. and Bottiger, B. (2011) Clinical and virological features of enterovirus 71 infections in Denmark, 2005 to 2008. Scand. J. Infect. Dis. 43, 642-648. https://doi.org/10.3109/00365548.2011.577094
  2. Cabrerizo, M., Tarrago, D., Munoz-Almagro, C., Del Amo, E., Dominguez-Gil, M., Eiros, J. M., Lopez-Miragaya, I., Perez, C., Reina, J., Otero, A., Gonzalez, I., Echevarria, J. E. and Trallero, G. (2014) Molecular epidemiology of enterovirus 71, coxsackievirus A16 and A6 associated with hand, foot and mouth disease in Spain. Clin. Microbiol. Infect. 20, O150-O156. https://doi.org/10.1111/1469-0691.12361
  3. Chang, L. Y., Lee, C. Y., Kao, C. L., Fang, T. Y., Lu, C. Y., Lee, P. I. and Huang, L. M. (2007) Hand, foot and mouth disease complicated with central nervous system involvement in Taiwan in 1980-1981. J. Formos. Med. Assoc. 106, 173-176. https://doi.org/10.1016/S0929-6646(09)60236-9
  4. Chang, L. Y., Lin, T. Y., Hsu, K. H., Huang, Y. C., Lin, K. L., Hsueh, C., Shih, S. R., Ning, H. C., Hwang, M. S., Wang, H. S. and Lee, C. Y. (1999) Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet 354, 1682-1686. https://doi.org/10.1016/S0140-6736(99)04434-7
  5. Chiang, L. C., Chang, J. S., Chen, C. C., Ng, L. T. and Lin, C. C. (2003) Anti-Herpes simplex virus activity of Bidens pilosa and Houttuynia cordata. Am. J. Chin. Med. 31, 355-362. https://doi.org/10.1142/S0192415X03001090
  6. Choi, H. J., Kim, J. H., Lee, C. H., Ahn, Y. J., Song, J. H., Baek, S. H. and Kwon, D. H. (2009a) Antiviral activity of quercetin 7-rhamnoside against porcine epidemic diarrhea virus. Antiviral Res. 81, 77-81. https://doi.org/10.1016/j.antiviral.2008.10.002
  7. Choi, H. J., Lim, C. H., Song, J. H., Baek, S. H. and Kwon, D. H. (2009b) Antiviral activity of raoulic acid from Raoulia australis against Picornaviruses. Phytomedicine 16, 35-39. https://doi.org/10.1016/j.phymed.2008.10.012
  8. De Clercq, E. (2004) Antiviral drugs in current clinical use. J. Clin. Virol. 30, 115-133. https://doi.org/10.1016/j.jcv.2004.02.009
  9. Hagiwara, A., Tagaya, I. and Yoneyama, T. (1978) Epidemic of hand, foot and mouth disease associated with enterovirus 71 infection. Intervirology 9, 60-63. https://doi.org/10.1159/000148922
  10. Kassab, S., Saghi, T., Boyer, A., Lafon, M. E., Gruson, D., Lina, B., Fleury, H. and Schuffenecker, I. (2013) Fatal case of enterovirus 71 infection and rituximab therapy, france, 2012. Emerging Infect. Dis. 19, 1345-1347.
  11. Kim, T. W., Kim, J. G., Yang, C., Ki, H., Jo, J. and Ihee, H. (2014) Pump-Probe X-ray Solution Scattering Reveals Accelerated Folding of Cytochrome Upon Suppression of Misligation. Bull. Korean Chem. Soc. 35, 695-696. https://doi.org/10.5012/bkcs.2014.35.3.695
  12. Kuo, R. L. and Shih, S. R. (2013). Strategies to develop antivirals against enterovirus 71. Virol. J. 10, 28. https://doi.org/10.1186/1743-422X-10-28
  13. Lamarao, L. M., Maciel, A. M. and Gomes Mde, L. (2003) First isolation of enterovirus 71 (EV-71) from Northern Brazil. Braz. J. Infect. Dis. 7, 278-281. https://doi.org/10.1590/S1413-86702003000400009
  14. Lum, L. C., Wong, K. T., Lam, S. K., Chua, K. B., Goh, A. Y., Lim, W. L., Ong, B. B., Paul, G., AbuBakar, S. and Lambert, M. (1998) Fatal enterovirus 71 encephalomyelitis. J. Pediatr. 133, 795-798. https://doi.org/10.1016/S0022-3476(98)70155-6
  15. McMinn, P. C. (2002) An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol. Rev. 26, 91-107. https://doi.org/10.1111/j.1574-6976.2002.tb00601.x
  16. Merovitz, L., Demers, A. M., Newby, D. and McDonald, J. (2000) Enterovirus 71 infections at a Canadian center. Pediatr. Infect. Dis. J. 19, 755-757. https://doi.org/10.1097/00006454-200008000-00017
  17. Mizuta, K., Abiko, C., Murata, T., Matsuzaki, Y., Itagaki, T., Sanjoh, K., Sakamoto, M., Hongo, S., Murayama, S. and Hayasaka, K. (2005) Frequent importation of enterovirus 71 from surrounding countries into the local community of Yamagata, Japan, between 1998 and 2003. J. Clin. Microbiol. 43, 6171-6175. https://doi.org/10.1128/JCM.43.12.6171-6175.2005
  18. Moghaddam, E., Teoh, B. T., Sam, S. S., Lani, R., Hassandarvish, P., Chik, Z., Yueh, A., Abubakar, S. and Zandi, K. (2014) Baicalin, a metabolite of baicalein with antiviral activity against dengue virus. Sci. Rep. 4, 5452.
  19. Oberste, M. S., Maher, K., Kilpatrick, D. R., Flemister, M. R., Brown, B. A. and Pallansch, M. A. (1999) Typing of human enteroviruses by partial sequencing of VP1. J. Clin. Microbiol. 37, 1288-1293.
  20. Schmidt, N. J., Lennette, E. H. and Ho, H. H. (1974) An apparently new enterovirus isolated from patients with disease of the central nervous system. J. Infect. Dis. 129, 304-309. https://doi.org/10.1093/infdis/129.3.304
  21. Schuffenecker, I., Mirand, A., Antona, D., Henquell, C., Chomel, J. J., Archimbaud, C., Billaud, G., Peigue-Lafeuille, H., Lina, B. and Bailly, J. L. (2011) Epidemiology of human enterovirus 71 infections in France, 2000-2009. J. Clin. Virol. 50, 50-56. https://doi.org/10.1016/j.jcv.2010.09.019
  22. Song, J., Yeo, S. G., Hong, E. H., Lee, B. R., Kim, J. W., Kim, J., Jeong, H., Kwon, Y., Kim, H., Lee, S., Park, J. H. and Ko, H. J. (2014) Antiviral Activity of Hederasaponin B from Hedera helix against Enterovirus 71 Subgenotypes C3 and C4a. Biomol. Ther. (Seoul) 22, 41-46. https://doi.org/10.4062/biomolther.2013.108
  23. Tan, X., Huang, X., Zhu, S., Chen, H., Yu, Q., Wang, H., Huo, X., Zhou, J., Wu, Y., Yan, D., Zhang, Y., Wang, D., Cui, A., An, H. and Xu, W. (2011) The persistent circulation of enterovirus 71 in People's Republic of China: causing emerging nationwide epidemics since 2008. PLoS ONE 6, e25662. https://doi.org/10.1371/journal.pone.0025662
  24. Venancio, P., Oliveira, M., Silva, R., Conceicao, C. and Brito, M. J. (2013) First case of severe enterovirus 71 infection in Portugal. Pediatr. Infect. Dis. J. 32, 581-582.
  25. Wang, S. M., Lei, H. Y., Huang, K. J., Wu, J. M., Wang, J. R., Yu, C. K., Su, I. J. and Liu, C. C. (2003) Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J. Infect. Dis. 188, 564-570. https://doi.org/10.1086/376998
  26. Wong, K. T., Lum, L. C. and Lam, S. K. (2000) Enterovirus 71 infection and neurologic complications. N. Engl. J. Med. 342, 356-358. https://doi.org/10.1056/NEJM200002033420514
  27. Xing, W., Liao, Q., Viboud, C., Zhang, J., Sun, J., Wu, J. T., Chang, Z., Liu, F., Fang, V. J., Zheng, Y., Cowling, B. J., Varma, J. K., Farrar, J. J., Leung, G. M. and Yu, H. (2014) Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet Infect. Dis. 14, 308-318. https://doi.org/10.1016/S1473-3099(13)70342-6

Cited by

  1. Labdane-type diterpenoids from Vitex limonifolia and their antivirus activities 2017, https://doi.org/10.1007/s11418-017-1125-2
  2. Antiviral activity of gemcitabine against human rhinovirus in vitro and in vivo vol.145, 2017, https://doi.org/10.1016/j.antiviral.2017.07.003
  3. Antiviral Activity of Itraconazole against Echovirus 30 Infection In Vitro vol.8, pp.5, 2016, https://doi.org/10.24171/j.phrp.2017.8.5.05
  4. Manassantin B shows antiviral activity against coxsackievirus B3 infection by activation of the STING/TBK-1/IRF3 signalling pathway vol.9, pp.None, 2016, https://doi.org/10.1038/s41598-019-45868-8
  5. Role of Some Food-Grade Synthesized Flavonoids on the Control of Ochratoxin A in Aspergillus carbonarius vol.24, pp.14, 2019, https://doi.org/10.3390/molecules24142553
  6. Flavonoids as Antiviral Agents for Enterovirus A71 ( EV - A71 ) vol.12, pp.2, 2020, https://doi.org/10.3390/v12020184
  7. Scutellaria baicalensis Flavones as Potent Drugs against Acute Respiratory Injury during SARS-CoV-2 Infection: Structural Biology Approaches vol.8, pp.11, 2020, https://doi.org/10.3390/pr8111468
  8. Broad Anti-Viral Capacities of Lian-Hua-Qing-Wen Capsule and Jin-Hua-Qing-Gan Granule and Rational use Against COVID-19 Based on Literature Mining vol.12, pp.None, 2021, https://doi.org/10.3389/fphar.2021.640782
  9. Norwogonin attenuates hypoxia-induced oxidative stress and apoptosis in PC12 cells vol.21, pp.1, 2016, https://doi.org/10.1186/s12906-020-03189-8